Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 May 2.
Published in final edited form as: Prev Med. 2012 Jun 5;55(0):S116–S117. doi: 10.1016/j.ypmed.2012.03.017

Optimizing financial incentives to improve health among military personnel: Differences by pay grade and across branches

Jody L Sindelar *, Nicholas Torsiello
PMCID: PMC3641555  NIHMSID: NIHMS460319  PMID: 22673693

The focus of this volume is to provide information on financial incentives to develop and sustain habits that can improve the health of military personnel. There are several reasons to use financial incentives in the military, including that the military already successfully relies on incentives to recruit and retain personnel. Furthermore, substantial evidence already indicates that financial incentives can improve health habits in the civilian population. They have been shown to reduce the use of illicit drugs (e.g., Higgins et al., 2008; Higgins et al., 2004; Lussier et al., 2006), help smokers to quit smoking (Heil et al., 2008; Volpp et al., 2006, 2009a; Sindelar, 2008), encourage others to lose weight (John et al., 2011; Volpp et al., 2008a) and address other health habits (Volpp et al., 2008b). However, research is needed in military populations to assess the effectiveness and cost-benefit of incentive systems as well as to adapt them to specifics of the military.

There is heterogeneity across military populations, specifically by branch of the military and by pay grade that might be potentially important in designing incentive systems (Volpp et al., 2011). Differences will likely occur in the costs of the programs, responsiveness to the incentives and the benefits accrued. These differences will affect the optimal design, implementation and selection of incentive programs for the military as well as the value obtained.

There are several important implications of this heterogeneity. One is that a single incentive system and level of payments may have differential effectiveness and benefit across population characteristics such as pay grade and branch of the service. There may not be a single cost–benefit value but rather multiple values depending on the size, structure, type and timing of payments and on the population under consideration. For instance, lower pay level groups may have a higher discount rate (Yoon et al., 2007) and thus may need reinforcement through more frequent incentives, however, the monetary amounts to encourage change may not need to be as high (Gourville, 1998; Volpp et al., 2009b). At higher pay grades, a larger amount of financial incentives may be needed, and the reinforcement may not need to be as frequent, but evidence is lacking in these areas. Furthermore, the military may place a higher value on health improvements for top personnel; the military has invested significantly in their training, expects them to be in the military longer and wants them to serve as role models.

A second and related point is that it may be valuable to tailor incentive systems to different pay grades or branches, or even to different levels of health (Stein et al., 2000). For example, if a particular group has a high rate of smoking and is very responsive to incentives, an incentive program is likely to offer greater value to the military and to taxpayers. These considerations suggest that the efficiency and cost-benefit of financial incentives should be analyzed with a focus on different sub-populations of the military. Empirical evidence is needed on the responsiveness to incentives and the cost-effectiveness by pay grade and branch of the military as there is little direct evidence to guide program development.

Smoking to illustrate key points

Smoking is considered to be the most important preventable cause of poor health in the US (CDC, 2010; DHHS, 2000, 2004). Smoking by those in the military imposes some unique costs. It directly harms health, job performance, and battle readiness (DHHS, 2000, 2004; IOM, 2009). Also, it is estimated that each year military hospitals spend nearly $500 million and the VA spends more than $5 billion on tobacco-related medical services (IOM, 2009). These expenditures represent potential benefits to reducing smoking, but the financial incentives represent additional costs. Weighing the costs and benefits to ensure value can be accomplished through cost–benefit analysis.

Cost–benefit analysis (CBA) basics

Cost–benefit analysis is a form of economic analysis often used in economic evaluations of programs designed to achieve specific goals such as improvement in health. In CBA, costs and benefits to all who are enrolled in a program are assessed in monetary terms and aggregated. A program with positive benefits compared to cost is desirable (i.e. net benefit), while those with the greatest net benefits are the most desirable. Note that when the benefits are multiple and difficult to put in pecuniary terms, cost-effectiveness analysis (CEA) is often used because outcomes can be compared (one at a time) to costs; nevertheless, the same points apply to CEA as to CBA with respect to heterogeneity.

Key to any CBA is to consider all benefits and assess their values, that is, who benefits and by how much. In the case of incentives to achieve smoking cessation, there are several potential beneficiaries: military personnel, their families and society at large. Benefits to the military personnel include better health while in the military, plus attendant benefits such as lower out-of pocket expenses for health care. In addition, benefits will spill over to family and others because of lessened exposure to second-hand smoke. Society at large will benefit from greater readiness for war, enhanced security and greater retention of human capital investment, which also will avoid costs of recruiting and training new personnel. Finally, taxpayers benefit from lower expenses for medical care for military personnel while active in the service and then later as veterans.

Costs of the incentive program have to be identified, measured and aggregated. Costs of the incentives themselves are the most obvious. Administrative costs of operating the program (e.g. testing and monitoring payments) also are relevant, and there may be economies of scale in implementing programs across branches of the government and pay groups. Hidden costs also need to be considered. In the case of tobacco use cessation, a hidden cost may be that of greater use of nicotine replacement therapies (e.g. the patch) and counseling, either of which may increase due to a higher motivation to quit. However, these extra costs likely will increase the effectiveness of the incentives and will be measured in the benefits.

Balancing the costs and benefits of incentives in the military

The purpose of cost–benefit analysis is to assess whether the higher costs are worthwhile in terms of better outcomes (Cahill and Perera, 2011). Both the benefits and the costs of incentive payments can depend on the characteristics of the population selected for the incentive system. For example, those who are most addicted to and smoking the most cigarettes may have the greatest potential gain from cessation. However, it may be most difficult to change their behavior, thus requiring higher payments, more frequent testing and complementary approaches.

There may be systematic differences in the responsiveness to incentives by pay grade and branch of the military. These would result in different cost–benefit outcomes across these sub-populations. Differences in the smoking rate in the military could also affect the value of the incentive system across groups. While 40% of the lowest paid enlisted individuals smoke, the smoking rate drops to 10% for Officers (grades 01–05) and only 5% for the highest pay grade Officers (Bray et al., 2009). Note that similarly, the smoking rate varies by education level in the US population. There are important differences between branches of the military as well, with the Marine Corps reporting the highest percentage of smokers (37%), followed by the Army (33%),Navy (31%), Coast Guard (28%) and Air Force (23%). The magnitude of the benefits and the costs from a specific incentive system will depend on the size and structure (e.g. escalating benefits) of the benefits, including: frequency of testing and paying incentives, method of testing for achievement of the outcomes (e.g., cotinine levels vs. self-report) and length of the incentive program and follow-up, among other behavioral factors (Haisley et al., 2012; Volpp et al., 2009b, 2011). Interestingly, higher and more frequent payments, more frequent testing and a longer program all increase effectiveness and benefits. However, they also tend to increase costs. Research in the military is needed to provide evidence on how to optimally tailor and design incentive programs across population sub-groups and military branches.

Conclusion

The recognition of potential heterogeneity in the effectiveness and cost–benefit of incentive systems across specific populations has several important policy implications. One is that any particular incentive system is likely to be more cost-beneficial for some groups than others. That is, greater value will be produced for different populations given the same program. One decision the military would face is whether to offer incentives to only those with the greatest net gain. However, the size, structure and other properties of the incentive system could be tailored to different branches and pay grades. This would maximize the value from incentives, but could result in offering different payments to different populations. Whether to offer to all populations the same incentive system, to offer incentives only to some populations or to tailor the system to different populations would become both an economic and political issue (e.g., see Volpp et al., 2011). For example, the military might offer the same incentives to all in order to be equitable. Alternatively, they might pay larger incentives based on responsiveness to the incentives, economies of scale in operation and/or benefits accrued. Thus, a critical question will be whether to implement incentives for all branches and all pay grades on the grounds of broad-based equity or to prioritize specific groups based on efficiency. Heterogeneity in responsiveness and costs may offer opportunities to improve incentive programs through tailoring.

Footnotes

Conflict of interest statement

The authors have no conflicts of interest to report.

References

  • 1.Bray RM, Pemberton MR, Hourani LL, et al. Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel: A Component of the Defense Lifestyle Assessment Program (DLAP) Research Triangle Park, NC: Research Triangle Institute International; 2009. Sep, [Google Scholar]
  • 2.Cahill K, Perera R. Competitions and incentives for smoking cessation. Cochrane Database Syst. Rev. 2011;4:CD004307. doi: 10.1002/14651858.CD004307.pub4. [DOI] [PubMed] [Google Scholar]
  • 3.Centers for Disease Control. Vital signs: current cigarette smoking among adults aged ≥18 years — United States, 2009. Morb. Mortal. Wkly. Rep. 2010 Sep 10;59(35):1135–1140. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5935a3.htm. [PubMed] [Google Scholar]
  • 4.Gourville JT. Pennies-a-day: the effect of temporal reframing on transaction evaluation. Journal of Consumer Research. 1998;24(4):395–408. [Google Scholar]
  • 5.Haisley E, Volpp K, Pellathy T, Loewenstein G. The impact of alternative incentive schemes on completion of health risk assessments. Am. J. Health Promot. 2012;26:184–188. doi: 10.4278/ajhp.100729-ARB-257. [DOI] [PubMed] [Google Scholar]
  • 6.Heil SH, Higgins ST, Bernstein IM, et al. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction. 2008;103:1009–1018. doi: 10.1111/j.1360-0443.2008.02237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Higgins ST, Budney AJ, Bickel WK, et al. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 2004;51:568–576. doi: 10.1001/archpsyc.1994.03950070060011. [DOI] [PubMed] [Google Scholar]
  • 8.Higgins ST, Silverman K, Heil SH, editors. Contingency Management in Substance Abuse Treatment. New York, NY: The Guilford Press; 2008. [Google Scholar]
  • 9.Institute of Medicine. Combating Tobacco Use in Military and Veteran Populations. Washington, DC: The National Academies Press; 2009. [PubMed] [Google Scholar]
  • 10.John L, Loewenstein G, Troxel A, Norton L, Fassbender J, Volpp K. Financial incentives for extended weight loss: a randomized, controlled trial. J. Gen. Intern. Med. 2011;26:621–626. doi: 10.1007/s11606-010-1628-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192–203. doi: 10.1111/j.1360-0443.2006.01311.x. [DOI] [PubMed] [Google Scholar]
  • 12.Sindelar JL. Paying for performance: the power of incentives over habits. Health Econ. 2008;17:449–451. doi: 10.1002/hec.1350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stein AD, Khoury Shakour S, Zuidema RA. Financial incentives, participation in employer-sponsored health promotion, and changes in employee health and productivity: healthplus health quotient program. J. Occup. Environ. Med. 2000;42(12):1148–1155. doi: 10.1097/00043764-200012000-00005. [DOI] [PubMed] [Google Scholar]
  • 14.US Department of Health and Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000. [Google Scholar]
  • 15.US Department of Health and Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. [Google Scholar]
  • 16.Volpp KG, Gurmankin Levy A, Asch DA, et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol. Biomarkers Prev. 2006;15:12–18. doi: 10.1158/1055-9965.EPI-05-0314. [DOI] [PubMed] [Google Scholar]
  • 17.Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: A randomized trial. JAMA. 2008a;300:2631–2637. doi: 10.1001/jama.2008.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv. Res. 2008b;8:272. doi: 10.1186/1472-6963-8-272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Volpp KG, et al. A randomized, controlled trial of financial incentives for smoking cessation. N. Eng. J. Med. 2009a;360:699–709. doi: 10.1056/NEJMsa0806819. [DOI] [PubMed] [Google Scholar]
  • 20.Volpp KG, Pauly MV, Loewenstein G, Bangsberg DR. P4P4P: an agenda for research on pay for performance for patients. Health Aff. 2009b;28:206–214. doi: 10.1377/hlthaff.28.1.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Volpp KG, Asch DA, Galvin R, Lowenstein G. Redesigning employee health incentives — lessons from behavioral economics. N. Eng. J. Med. 2011;365:388–390. doi: 10.1056/NEJMp1105966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yoon JH, Higgins ST, Heil SH, Sugarbaker RJ, Thomas CS, Badger GJ. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp. Clin. Psychopharmacol. 2007;15:176–186. doi: 10.1037/1064-1297.15.2.186. [DOI] [PubMed] [Google Scholar]

RESOURCES